Skip to main content

Table 1 Demographics of n = 20 patients with gout at baseline

From: Xanthine oxidase inhibitor urate-lowering therapy titration to target decreases serum free fatty acids in gout and suppresses lipolysis by adipocytes

 

Baseline

Age

60.4 ± 11.1

Gender

100% M

Race

7 W, 5 AA, 3 A, 4 PI, 1 NA

DM (n)

7 (4 on metformin, 3 on insulin)

DL (n)

15 (10 on statins)

HBP (n)

18

Flares per year

4.48 ± 3.35

Uric acid

8.34 ± 1.2

BMI

31.7 ± 4.4

ALT

31.6 ± 13

AST

38.1 ± 30.1

TG

225.94 ± 124.4

LDL

94.1 ± 34.8

  1. M male, W white, AA African American, A Asian, PI pacific-islanders, NA native-American, DM diabetes mellitus, DL dyslipidemia, HBP high blood pressure, BMI body mass index, TG triglycerides, LDL low-density lipoproteins